Inhibrx Biosciences (INBX) Prepaid Assets (2023 - 2026)
Inhibrx Biosciences (INBX) posted quarterly Prepaid Assets of $8.4 million for Q4 2025, up 2108.12% year-over-year from $382000.0 in Q4 2024, and up 1957.32% quarter-over-quarter from $410000.0 in Q3 2025.
Analysis
Inhibrx Biosciences (INBX) Prepaid Assets (2023 - 2026) Analysis & Trends
Inhibrx Biosciences (INBX) has reported Prepaid Assets for 3 consecutive years, with $8.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets rose 2108.12% year-over-year to $8.4 million; the TTM figure through Dec 2025 stood at $8.4 million (up 2108.12% YoY), while the FY2025 annual figure was $8.4 million, up 2108.12% from the prior year.
- Prepaid Assets improved to $8.4 million in Q4 2025 per INBX's latest filing, from $410000.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $8.4 million in Q4 2025 and bottomed at $269000.0 in Q1 2025.
- Historically, Prepaid Assets has averaged $1.5 million across 3 years, with a median of $396000.0 in 2024.
- On a YoY basis, Prepaid Assets climbed as much as 2108.12% in 2025 and fell as far as 70.7% in 2025.
- Inhibrx Biosciences' Prepaid Assets stood at $366000.0 in 2023, then climbed by 4.37% to $382000.0 in 2024, then soared by 2108.12% to $8.4 million in 2025.
- Business Quant data shows INBX's Prepaid Assets at $8.4 million in Q4 2025, $410000.0 in Q3 2025, and $283000.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Inhibrx Biosciences | 1.91 Bn | 1.91 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.74 Mn |
| Dec 31, 2025 | 8.44 Mn |
| Sep 30, 2025 | 7.50 Mn |
| Jun 30, 2025 | 6.43 Mn |
| Mar 31, 2025 | 6.65 Mn |
| Dec 31, 2024 | 7.38 Mn |
| Sep 30, 2024 | 9.99 Mn |
| Jun 30, 2024 | 13.81 Mn |
| Dec 31, 2023 | 16.66 Mn |